Terms: = Bone cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
19 results:
1. Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Sun Z; Bai C; Su M; Tang H; Wu X; Wang Y; Bao H; Liu X; Wu X; Shao Y; Xu B
Mol Oncol; 2023 Sep; 17(9):1917-1929. PubMed ID: 37013911
[TBL] [Abstract] [Full Text] [Related]
2. IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy.
Tunalı G; Rúbies Bedós M; Nagarajan D; Fridh P; Papakyriacou I; Mao Y
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36757800
[TBL] [Abstract] [Full Text] [Related]
3. cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway.
Liu Y; Yang C; Chen S; Liu W; Liang J; He S; Hui J
Cancer Gene Ther; 2023 Mar; 30(3):437-449. PubMed ID: 36434177
[TBL] [Abstract] [Full Text] [Related]
4. Changes in bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma.
Dhodapkar KM; Cohen AD; Kaushal A; Garfall AL; Manalo RJ; Carr AR; McCachren SS; Stadtmauer EA; Lacey SF; Melenhorst JJ; June CH; Milone MC; Dhodapkar MV
Blood Cancer Discov; 2022 Nov; 3(6):490-501. PubMed ID: 36026513
[TBL] [Abstract] [Full Text] [Related]
5. PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Funk CR; Wang S; Chen KZ; Waller A; Sharma A; Edgar CL; Gupta VA; Chandrakasan S; Zoine JT; Fedanov A; Raikar SS; Koff JL; Flowers CR; Coma S; Pachter JA; Ravindranathan S; Spencer HT; Shanmugam M; Waller EK
Blood; 2022 Jan; 139(4):523-537. PubMed ID: 35084470
[TBL] [Abstract] [Full Text] [Related]
6. Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
Zeidner JF; Vincent BG; Ivanova A; Moore D; McKinnon KP; Wilkinson AD; Mukhopadhyay R; Mazziotta F; Knaus HA; Foster MC; Coombs CC; Jamieson K; Van Deventer H; Webster JA; Prince GT; DeZern AE; Smith BD; Levis MJ; Montgomery ND; Luznik L; Serody JS; Gojo I
Blood Cancer Discov; 2021 Nov; 2(6):616-629. PubMed ID: 34778801
[TBL] [Abstract] [Full Text] [Related]
7. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract] [Full Text] [Related]
8. Integrated bioinformatic analysis of hnf1a in human cancers.
Zhang E; Huang X; He J
J Int Med Res; 2021 Mar; 49(3):300060521997326. PubMed ID: 33752475
[TBL] [Abstract] [Full Text] [Related]
9. Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia.
von Heydebrand F; Fuchs M; Kunz M; Voelkl S; Kremer AN; Oostendorp RAJ; Wilke J; Leitges M; Egle A; Mackensen A; Lutzny-Geier G
Stem Cells; 2021 Jun; 39(6):819-830. PubMed ID: 33539629
[TBL] [Abstract] [Full Text] [Related]
10. Long Noncoding RNA hnf1a-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis.
Lou P; Ding T; Zhan X
Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998
[No Abstract] [Full Text] [Related]
11. Risk-associated alterations in marrow T cells in pediatric leukemia.
Bailur JK; McCachren SS; Pendleton K; Vasquez JC; Lim HS; Duffy A; Doxie DB; Kaushal A; Foster C; DeRyckere D; Castellino S; Kemp ML; Qiu P; Dhodapkar MV; Dhodapkar KM
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32692727
[TBL] [Abstract] [Full Text] [Related]
12. Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.
Bailur JK; McCachren SS; Doxie DB; Shrestha M; Pendleton K; Nooka AK; Neparidze N; Parker TL; Bar N; Kaufman JL; Hofmeister CC; Boise LH; Lonial S; Kemp ML; Dhodapkar KM; Dhodapkar MV
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013254
[TBL] [Abstract] [Full Text] [Related]
13. The lncRNA hnf1a-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma.
Cai L; Lv J; Zhang Y; Li J; Wang Y; Yang H
J Cell Mol Med; 2017 Nov; 21(11):2654-2662. PubMed ID: 28866868
[TBL] [Abstract] [Full Text] [Related]
14. Andrographolide Induces Cell Cycle Arrest and Apoptosis of Chondrosarcoma by Targeting TCF-1/SOX9 Axis.
Zhang HT; Yang J; Liang GH; Gao XJ; Sang Y; Gui T; Liang ZJ; Tam MS; Zha ZG
J Cell Biochem; 2017 Dec; 118(12):4575-4586. PubMed ID: 28485543
[TBL] [Abstract] [Full Text] [Related]
15. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract] [Full Text] [Related]
16. Erdheim-Chester disease with novel gene mutations discovered as an incidental finding in explanted liver of a patient with hepatitis C cirrhosis: A case report and literature review.
Liao X; Thorson JA; Hughes T; Nguyen JC; Wang HY; Lin GY
Pathol Res Pract; 2016 Sep; 212(9):849-54. PubMed ID: 27445228
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.
Hu B; Chen Y; Usmani SZ; Ye S; Qiang W; Papanikolaou X; Heuck CJ; Yaccoby S; Williams BO; Van Rhee F; Barlogie B; Epstein J; Qiang YW
PLoS One; 2013; 8(9):e74191. PubMed ID: 24066119
[TBL] [Abstract] [Full Text] [Related]
18. beta-Catenin expression enhances generation of mature thymocytes.
Mulroy T; Xu Y; Sen JM
Int Immunol; 2003 Dec; 15(12):1485-94. PubMed ID: 14645157
[TBL] [Abstract] [Full Text] [Related]
19. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells.
Toor AA; Lund TC; Miller JS
Exp Hematol; 2001 Apr; 29(4):499-506. PubMed ID: 11301190
[TBL] [Abstract] [Full Text] [Related]
